TheStreet: Stock Quotes, Financial Market News, & Investment Advice

Vote in our Poll

Who Will Win the Chocolate War?

Will Cadbury, Kraft, Hershey's -- or the chocolatier pairing of Hershey's and Ferrero -- prevail in the battle for Cadbury? Take our poll to see what TheStreet says.

Most Commented Story Today

Biotech Stock Mailbag: FDA Playbook

Smart drug and biotech companies keep the FDA abreast of their clinical trial program throughout the long drug-development process.

Videos

BUY CSX!: Against the Grain

WESTCHESTER COUNTY, NEW YORK -- Marek Fuchs tells CSX to ignore an analyst's about face and buy. Plus, performance review.

Videos

New IPOs Are a Key Market Tell: 1-Minute Trade

NEW YORK (TheStreet) -- David Peltier discusses how today's 4 new IPO's could set the tone for trading over the next week.

Videos

Why Gold Won't Quit

NEW YORK (The Street) - David Morgan, founder of Silver-Investor.com, says that gold is in desperate need of a correction but momentum funds keep buying. He reveals why and how high gold prices will go.

Commentary

Green U.S. Jobs to Come From China

Two recent announcements may herald a new trend: Chinese alternative energy companies setting up plants in the U.S.

Stanley Bing

Back Off, Santa

Stanley Bing wishes retailers would leave Christmas alone and let it start when it usually does.

Best in Class Business

ClickSoftware Offers Value Amid the Bust: Best in Class

ClickSoftware Technologies appears to be in the right place at the right time, as companies are being forced to do more with less.

Between the Lines
Banks & Insurers
Japan Banks: Financial Winners & Losers

Yesterday's bloodbath in the financial sector continues on Friday, but Lazard and Morgan Stanley are no longer leading the retreat, while the sun rose today on some big name Japanese financials in a big way.

Technology
Cloud Peak Slips Amid Mixed Bag for IPOs

Cloud Peak Energy, Archipelago Learning and Global Defense Technology are enjoying mixed fortunes on their IPO debuts.

Biotech
Biotech Stock Mailbag: FDA Playbook

Smart drug and biotech companies keep the FDA abreast of their clinical trial program throughout the long drug-development process.

ETFs
Professor Buffett Tutors Goldman

Warren Buffett helps Goldman Sachs out of a messy situation by participating in a $500 million philanthropic plan to help small businesses.

Earnings
Homebuilder Losers: Horton Hears a Boo

D.R. Horton's weak earnings sent shares of homebuilders tumbling all day, wiping out much of the gains racked up in the sector since Toll Brothers reported positive numbers two weeks ago.

IPOs
IPO Watch: Offerings Rake in $890 Million

Five IPOs, in all, came to market this week, totaling $890 million.

Mergers & Acquisitions
GE, Vivendi Differ on Value of NBCU Stake

General Electric and Vivendi are at least $1 billion apart in their valuation of the French media company's stake in NBC Universal, a report says.

TheStreet Ratings
Five Mid-Cap Stocks Ready to Run

Church & Dwight, Tyler Technologies, Check Point Software and Balchem are rated 'buy' by TheStreet.com.

Winners & Losers
Japan Banks: Financial Winners & Losers

Yesterday's bloodbath in the financial sector continues on Friday, but Lazard and Morgan Stanley are no longer leading the retreat, while the sun rose today on some big name Japanese financials in a big way.

Try RealMoney Free Trial Now
Who is Bullish on RealMoney Today See all RealMoney Gurus

Connect with TheStreet

Dow Jones S&P 500 NASDAQ 10-Year Note
10,318.16 1,091.38 2,146.04 33.56
Oil *
77.53
DOWN
14.28
DOWN
3.52
DOWN
10.78
UP
0.07
10 Yr
3.36%
SPDR Gold
112.94
-0.14%
-0.32%
-0.50%
+0.21%
Data delayed 20 minutes

Brokerage Partners

TheStreet Premium Services

All Services